D-0798-2020 Class II Terminated
FDA drug recall D-0798-2020 was initiated by RemedyRepack Inc. on Dec 11, 2019 and is designated Class II. Reason for recall: CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels. The recall status is terminated (terminated Jul 23, 2020). Affected quantity: 4,486 tablets.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 29, 2020
- Initiation Date
- Dec 11, 2019
- Termination Date
- Jul 23, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,486 tablets
Product description
Ranitidine 150 mg tablet Original Supplier's NDC 65162-0253-10 Remedy Repackaged NDC 70518-1714-00
Reason for recall
CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.
Distribution pattern
Product was distributed to two facilities in CA and NY.
Code information
Lot #: J0376034-052319, exp. date 05/2020 Lot #: J0406133-093019, exp. date 10/2020 Lot #: J038005-082719, exp. date 08/2020 Lot #: J0390280-072519, exp. date 07/2020 Lot #: J0390277-072519, exp. date 07/2020 Lot #: J0349352-012519, exp. date 01/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0798-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026